Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1973 2
1974 1
1975 2
1979 2
1981 3
1983 4
1984 5
1987 5
1988 1
1989 4
1990 1
1992 1
2005 1
2007 1
2008 1
2009 1
2010 2
2011 3
2012 3
2013 4
2014 3
2015 4
2016 2
2017 3
2018 2
2019 2
2021 1
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, Shaw W, Law G, Desai M, Matthews DR; CANVAS Program Collaborative Group. Neal B, et al. N Engl J Med. 2017 Aug 17;377(7):644-657. doi: 10.1056/NEJMoa1611925. Epub 2017 Jun 12. N Engl J Med. 2017. PMID: 28605608 Free article. Clinical Trial.
Liraglutide and Renal Outcomes in Type 2 Diabetes.
Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators. Mann JFE, et al. N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011. N Engl J Med. 2017. PMID: 28854085 Free article. Clinical Trial.
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.
Pfeffer MA, Claggett B, Diaz R, Dickstein K, Gerstein HC, Køber LV, Lawson FC, Ping L, Wei X, Lewis EF, Maggioni AP, McMurray JJ, Probstfield JL, Riddle MC, Solomon SD, Tardif JC; ELIXA Investigators. Pfeffer MA, et al. N Engl J Med. 2015 Dec 3;373(23):2247-57. doi: 10.1056/NEJMoa1509225. N Engl J Med. 2015. PMID: 26630143 Free article. Clinical Trial.
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.
Hernandez AF, Green JB, Janmohamed S, D'Agostino RB Sr, Granger CB, Jones NP, Leiter LA, Rosenberg AE, Sigmon KN, Somerville MC, Thorpe KM, McMurray JJV, Del Prato S; Harmony Outcomes committees and investigators. Hernandez AF, et al. Lancet. 2018 Oct 27;392(10157):1519-1529. doi: 10.1016/S0140-6736(18)32261-X. Epub 2018 Oct 2. Lancet. 2018. PMID: 30291013 Free article. Clinical Trial.
Ticagrelor in Patients with Stable Coronary Disease and Diabetes.
Steg PG, Bhatt DL, Simon T, Fox K, Mehta SR, Harrington RA, Held C, Andersson M, Himmelmann A, Ridderstråle W, Leonsson-Zachrisson M, Liu Y, Opolski G, Zateyshchikov D, Ge J, Nicolau JC, Corbalán R, Cornel JH, Widimský P, Leiter LA; THEMIS Steering Committee and Investigators. Steg PG, et al. N Engl J Med. 2019 Oct 3;381(14):1309-1320. doi: 10.1056/NEJMoa1908077. Epub 2019 Sep 1. N Engl J Med. 2019. PMID: 31475798 Free article. Clinical Trial.
Increasing the complexity of lipoprotein characterization for cardiovascular risk in type 2 diabetes.
Guardiola M, Rehues P, Amigó N, Arrieta F, Botana M, Gimeno-Orna JA, Girona J, Martínez-Montoro JI, Ortega E, Pérez-Pérez A, Sánchez-Margalet V, Pedro-Botet J, Ribalta J; Cardiovascular Disease Group of the Spanish Society of Diabetes. Guardiola M, et al. Eur J Clin Invest. 2024 Apr 13:e14214. doi: 10.1111/eci.14214. Online ahead of print. Eur J Clin Invest. 2024. PMID: 38613414 Review.
Deeper insight on Wolfram's syndrome.
Garcia-Luna PP, Villechenous-Pineda E, Leal-Cerro A, Duran-Garcia S, Jorge S, Nuñez-Roldan A, Astorga-Jimenez R. Garcia-Luna PP, et al. Among authors: duran garcia s. Diabetes Care. 1987 Jul-Aug;10(4):531-2. doi: 10.2337/diacare.10.4.531. Diabetes Care. 1987. PMID: 3622212 No abstract available.
Characteristics of pregnant women with diabetes using injectable glucose-lowering drugs in the EVOLVE study.
Mathiesen ER, Ali N, Anastasiou E, Cypryk K, de Valk HW, Dores JM, Dunne FP, Ekelund M, Durán García S, Hanaire H, Husemoen LLN, Ivanisevic M, Kempe HP, Nordsborg RB, McCance DR. Mathiesen ER, et al. Among authors: duran garcia s. J Matern Fetal Neonatal Med. 2022 Dec;35(25):7992-8000. doi: 10.1080/14767058.2021.1940132. Epub 2021 Jun 28. J Matern Fetal Neonatal Med. 2022. PMID: 34182866
[The dawn phenomenon in diabetic pregnancy].
Fernández I, Costa CJ, Rodríguez MA, Gutiérrez A, Griera JL, Durán García S. Fernández I, et al. Among authors: duran garcia s. Med Clin (Barc). 1990 Jan 20;94(2):46-8. Med Clin (Barc). 1990. PMID: 2184290 Spanish.
[Pioglitazone. Review of its metabolic and systemic effects].
Rodríguez Bernardino A, Cebrián Blanco S, Durán García S. Rodríguez Bernardino A, et al. Among authors: duran garcia s. Rev Clin Esp. 2005 Dec;205(12):610-20. doi: 10.1016/s0014-2565(05)72655-2. Rev Clin Esp. 2005. PMID: 16527183 Review. Spanish.
61 results